Alkermes plc (NASDAQ: ALKS) started the day on Thursday, with a price decrease of -4.44% at $30.8, before settling in for the price of $32.23 at the close. Taking a more long-term approach, ALKS posted a 52-week range of $25.17-$36.45.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -44.68%. This publicly-traded company’s shares outstanding now amounts to $165.05 million, simultaneously with a float of $161.01 million. The organization now has a market capitalization sitting at $5.08 billion. At the time of writing, stock’s 50-day Moving Average stood at $29.02, while the 200-day Moving Average is $30.20.
Alkermes plc (ALKS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. Alkermes plc’s current insider ownership accounts for 2.46%, in contrast to 102.50% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’25, this organization’s EVP R&D, Chief Medical Officer sold 9,000 shares at the rate of 31.53, making the entire transaction reach 283,776 in total value, affecting insider ownership by 73,740.
Alkermes plc (ALKS) Earnings and Revenue Records
Alkermes plc’s EPS decrease for this current 12-month fiscal period is -44.68% and is forecasted to reach 1.57 in the upcoming year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Let’s observe the current performance indicators for Alkermes plc (ALKS). It’s Quick Ratio in the last reported quarter now stands at 2.85. Alongside those numbers, its PE Ratio stands at $14.78, and its Beta score is 0.53. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.38. Similarly, its price to free cash flow for trailing twelve months is now 10.60.
In the same vein, ALKS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.08, a figure that is expected to reach 0.38 in the next quarter, and analysts are predicting that it will be 1.57 at the market close of one year from today.
Technical Analysis of Alkermes plc (ALKS)
If we take a close look at the recent performances of Alkermes plc (NASDAQ: ALKS), its last 5-days Average volume was 2.21 million that shows progress from its year to date volume of 1.81 million. During the previous 9 days, stock’s Stochastic %D was recorded 63.19% While, its Average True Range was 51.61.
Raw Stochastic average of Alkermes plc (ALKS) in the period of the previous 100 days is set at 77.89%, which indicates a major rise in contrast to 66.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.94 that was higher than 0.86 volatility it exhibited in the past 100-days period.
